삼익제약(주)

{
  "address": "인천광역시 부평구",
  "ceo_name": "이충환, 권영이",
  "certificate": [
    {
      "cert_number": "20180110422",
      "changes": "",
      "disclosure_date": "2018-08-30",
      "first_cert_date": "2018-08-30",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-08-30 ~ 2020-08-29"
    },
    {
      "cert_number": "20200112016",
      "changes": "",
      "disclosure_date": "2020-09-14",
      "first_cert_date": "2018-08-30",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-08-30 ~ 2022-08-29"
    },
    {
      "cert_number": "20221020030148",
      "changes": "",
      "disclosure_date": "2022-10-20",
      "first_cert_date": "2018-08-30",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2022-08-30 ~ 2025-08-29"
    },
    {
      "cert_number": "20250827030059",
      "changes": "",
      "disclosure_date": "2025-08-27",
      "first_cert_date": "2018-08-30",
      "no": "4",
      "type": "혁신성장유형",
      "valid_period": "2025-08-30 ~ 2028-08-29"
    }
  ],
  "company_name": "삼익제약(주)",
  "corp_no": "120111-*******",
  "financials": {
    "2022": {
      "capital_stock": 702500000,
      "cost_of_sales": 18665677000,
      "current_assets": 25487768000,
      "current_liabilities": 9090024000,
      "gross_profit": 28093083000,
      "net_income": 366835000,
      "net_income_bs": 343912000,
      "non_current_assets": 29617511000,
      "non_current_liabilities": 60239000,
      "non_operating_expenses": 418361000,
      "non_operating_income": 566458000,
      "operating_profit": 218738000,
      "revenue": 46758760000,
      "sga_expenses": 27874345000,
      "total_assets": 55105279000,
      "total_equity": 45955016000,
      "total_liabilities": 9150263000
    },
    "2023": {
      "capital_stock": 702500000,
      "cost_of_sales": 16883390000,
      "current_assets": 28415725000,
      "current_liabilities": 8838109000,
      "gross_profit": 33616867000,
      "net_income": 3471656000,
      "net_income_bs": 3003261000,
      "non_current_assets": 30368781000,
      "non_current_liabilities": 1794156000,
      "non_operating_expenses": 91203000,
      "non_operating_income": 708339000,
      "operating_profit": 2854520000,
      "revenue": 50500257000,
      "sga_expenses": 30762347000,
      "total_assets": 58784506000,
      "total_equity": 48152241000,
      "total_liabilities": 10632265000
    },
    "2024": {
      "capital_stock": 714950000,
      "cost_of_sales": 16684219000,
      "current_assets": 30454144000,
      "current_liabilities": 10237799000,
      "gross_profit": 37820302000,
      "net_income": 4150878000,
      "net_income_bs": 3342210000,
      "non_current_assets": 33260201000,
      "non_current_liabilities": 1884046000,
      "non_operating_expenses": 49821000,
      "non_operating_income": 715329000,
      "operating_profit": 3485370000,
      "revenue": 54504521000,
      "sga_expenses": 34334932000,
      "total_assets": 63714345000,
      "total_equity": 51592500000,
      "total_liabilities": 12121845000
    }
  },
  "industry": "합성의약품 및 기타 완제 의약품 제조업",
  "investment": [],
  "main_products": "전문의약품",
  "phone": "02-928-****",
  "years": [
    2024,
    2023,
    2022
  ]
}